AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33389521 — intervention group
Group type: EXPERIMENTAL
Intervention: 1:1 mixture of betamethasone phosphate and acetate (BET-PA) administered intramuscularly (IM)
Number of subjects: 48
Study 33181081 — intervention group
Group type: EXPERIMENTAL
Intervention: Febuxostat (80 mg/day, increasing to 120 mg/day if necessary)
Number of subjects: 6128
Study 33181081 — intervention group
Group type: COMPARATOR
Intervention: Allopurinol (optimised dose)
Number of subjects: 6128
Study 33181081 — intervention group
Group type: EXPERIMENTAL
Intervention: Febuxostat
Number of subjects: 6128
Study 33181081 — intervention group
Group type: COMPARATOR
Intervention: Allopurinol
Number of subjects: 6128
Study 34119741 — intervention group
Group type: EXPERIMENTAL
Intervention: JianpiQinghua (JQ) granules (34.8 g) plus omeprazole (10 mg)
Number of subjects: 204
Study 34119741 — intervention group
Group type: COMPARATOR
Intervention: Omeprazole (20 mg)
Number of subjects: 204
Study 32133684 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital Patient Journey (DPJ) solution
Number of subjects: 66
Study 32133684 — intervention group
Group type: COMPARATOR
Intervention: Conventional care (control)
Number of subjects: 66
Study 35717703 — intervention group
Group type: EXPERIMENTAL
Intervention: This Girl Can campaign (multi-session exposure)
Number of subjects: 339
Study 35717703 — intervention group
Group type: COMPARATOR
Intervention: Control videos/images depicting idealized women of thin/athletic body types
Number of subjects: 339
Study 35717703 — intervention group
Group type: COMPARATOR
Intervention: Control videos highlighting physical activity benefits
Number of subjects: 339
Study 33445218 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic cyanoacrylate injection
Number of subjects: 64
Study 33445218 — intervention group
Group type: COMPARATOR
Intervention: Balloon-occluded retrograde transvenous obliteration (BRTO)
Number of subjects: 64
Study 32192350 — intervention group
Group type: EXPERIMENTAL
Intervention: Stereotactic body radiotherapy (SBRT)
Number of subjects: 49
Study 36494649 — intervention group
Group type: EXPERIMENTAL
Intervention: Salad bar intervention in 70 schools (half of the matched pairs)
Number of subjects: 141
Study 36494649 — intervention group
Group type: COMPARATOR
Intervention: Pre-portioned fruits and vegetables only in 71 schools (half of the matched pairs)
Number of subjects: 141
Study 32623646 — intervention group
Group type: EXPERIMENTAL
Intervention: US-guided (USG) knee procedures
Number of subjects: 41
Study 32623646 — intervention group
Group type: COMPARATOR
Intervention: Landmark-guided (LMG) knee procedures
Number of subjects: 41
Study 33032180 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic oral nutritional supplements (ONS) from the beginning of CCRT
Number of subjects: 114
Study 33032180 — intervention group
Group type: COMPARATOR
Intervention: Control group received nutritional support only when necessary
Number of subjects: 114
Study 34071293 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation (10,000 IU daily for 14 days)
Number of subjects: 42
Study 34071293 — intervention group
Group type: COMPARATOR
Intervention: Control group (no supplementation)
Number of subjects: 42
Study 34071293 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation
Number of subjects: 42
Study 34071293 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 42
Study 34980026 — intervention group
Group type: EXPERIMENTAL
Intervention: PHI-101 (Chk2 inhibitor)
Number of subjects: 36
Study 33837890 — intervention group
Group type: EXPERIMENTAL
Intervention: Communities That Care (CTC) prevention system
Number of subjects: 4407
Study 35604694 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 33054601 — intervention group
Group type: EXPERIMENTAL
Intervention: Training (10 months)
Number of subjects: 49
Study 33054601 — intervention group
Group type: EXPERIMENTAL
Intervention: Detraining (5 months after 10 months training)
Number of subjects: 49
Study 35041454 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcatheter Aortic Valve Replacement (TAVR)
Number of subjects: 3025
Study 35041454 — intervention group
Group type: COMPARATOR
Intervention: Surgical Aortic Valve Replacement (SAVR)
Number of subjects: 3025
Study 34509423 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep-learning model for segmentation of geographic atrophy
Number of subjects: 200
Study 34509423 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep-learning model for segmentation of retinal pigment epithelium loss
Number of subjects: 200
Study 34509423 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep-learning model for segmentation of overlying photoreceptor degeneration
Number of subjects: 200
Study 34509423 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep-learning model for segmentation of hypertransmission
Number of subjects: 200
Study 34509423 — intervention group
Group type: COMPARATOR
Intervention: Human specialist grading
Number of subjects: 200
Study 36116545 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 °C saline irrigation
Number of subjects: 48
Study 36116545 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 °C saline irrigation
Number of subjects: 48
Study 36116545 — intervention group
Group type: COMPARATOR
Intervention: 25 °C saline irrigation (control)
Number of subjects: 48
Study 34209617 — intervention group
Group type: EXPERIMENTAL
Intervention: 1500 mg/day of Golden Root Extract (GRE; Rhodiola rosea)
Number of subjects: 10
Study 34209617 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL; gluten‐free cornstarch)
Number of subjects: 10
Study 32517382 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeated Sprint Ability Test (RSA)
Number of subjects: 25
Study 32517382 — intervention group
Group type: EXPERIMENTAL
Intervention: Yo-Yo Intermittent Recovery Test Level 1 (YYIR1)
Number of subjects: 25
Study 32517382 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-min LnSDNN:LnRMSSD ratio
Number of subjects: 25
Study 32517382 — intervention group
Group type: EXPERIMENTAL
Intervention: HRVUST LnSDNN:LnRMSSD ratio
Number of subjects: 25
Study 35912804 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition program, physical activity, synbiotic Acidolac, and vitamin D3 for 3 months
Number of subjects: 130
Study 35912804 — intervention group
Group type: COMPARATOR
Intervention: Standard care (nutrition program and physical activity) for 3 months
Number of subjects: 130
Study 34328433 — intervention group
Group type: COMPARATOR
Intervention: Group exercise program (delivered online)
Number of subjects: 241
Study 34328433 — intervention group
Group type: COMPARATOR
Intervention: Personal exercise program (delivered online)
Number of subjects: 241
Study 32534728 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertriglyceridemia (HTG) prevalence
Number of subjects: 6588
Study 32534728 — intervention group
Group type: EXPERIMENTAL
Intervention: Sex- and age-adjusted HTG prevalence
Number of subjects: 6588
Study 32534728 — intervention group
Group type: EXPERIMENTAL
Intervention: Triglyceride levels
Number of subjects: 6588
Study 32534728 — intervention group
Group type: EXPERIMENTAL
Intervention: Triglyceride levels in men
Number of subjects: 6588
Study 32534728 — intervention group
Group type: EXPERIMENTAL
Intervention: Triglyceride levels in women
Number of subjects: 6588
Study 32534728 — intervention group
Group type: EXPERIMENTAL
Intervention: Association with hypercholesterolemia
Number of subjects: 6588
Study 32534728 — intervention group
Group type: EXPERIMENTAL
Intervention: Association with low HDL-C
Number of subjects: 6588
Study 32534728 — intervention group
Group type: EXPERIMENTAL
Intervention: Association with hepatic steatosis
Number of subjects: 6588
Study 32534728 — intervention group
Group type: EXPERIMENTAL
Intervention: Association with diabetes
Number of subjects: 6588
Study 32534728 — intervention group
Group type: EXPERIMENTAL
Intervention: Association with obesity
Number of subjects: 6588
Study 35083729 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic drops containing Limosilactobacillus reuteri (DSM 17938 and ATCC PTA 5289) given as 5 daily drops at bedtime for 12 months.
Number of subjects: 38
Study 35083729 — intervention group
Group type: COMPARATOR
Intervention: Placebo drops (identically composed but lacking bacteria) given for 12 months.
Number of subjects: 38
Study 35083729 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic drops
Number of subjects: 38
Study 35083729 — intervention group
Group type: COMPARATOR
Intervention: Placebo drops
Number of subjects: 38
Study 35869984 — intervention group
Group type: EXPERIMENTAL
Intervention: pegcetacoplan
Number of subjects: 0
Study 35869984 — intervention group
Group type: COMPARATOR
Intervention: eculizumab
Number of subjects: 0
Study 34890354 — intervention group
Group type: EXPERIMENTAL
Intervention: Pink Journey app (intervention group)
Number of subjects: 96
Study 34890354 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 96
Study 34658247 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban monotherapy
Number of subjects: 2215
Study 34658247 — intervention group
Group type: COMPARATOR
Intervention: Combination therapy with rivaroxaban plus antiplatelet drug
Number of subjects: 2215
Study 36484671 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-implant mandibular overdenture (SIMO)
Number of subjects: 32
Study 36484671 — intervention group
Group type: COMPARATOR
Intervention: Conventional mandibular denture (CMD)
Number of subjects: 32
Study 33706185 — intervention group
Group type: EXPERIMENTAL
Intervention: Sunscreen products (4 commercially available types)
Number of subjects: 0
Study 33706185 — intervention group
Group type: EXPERIMENTAL
Intervention: LC-MS/MS method for avobenzone and oxybenzone
Number of subjects: 0
Study 32235852 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesiologist-guided functional training in addition to intradialytic cycling
Number of subjects: 40
Study 32235852 — intervention group
Group type: COMPARATOR
Intervention: Intradialytic cycling only
Number of subjects: 40
Study 33368797 — intervention group
Group type: EXPERIMENTAL
Intervention: Gilteritinib plus Azacitidine
Number of subjects: 0
Study 33368797 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 32556409 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous graft for EAS repair
Number of subjects: 0
Study 32556409 — intervention group
Group type: EXPERIMENTAL
Intervention: Biological graft for EAS repair
Number of subjects: 0
Study 32556409 — intervention group
Group type: EXPERIMENTAL
Intervention: Mesh graft for EAS repair
Number of subjects: 0
Study 32556409 — intervention group
Group type: EXPERIMENTAL
Intervention: Overly tight repair
Number of subjects: 0
Study 32556409 — intervention group
Group type: EXPERIMENTAL
Intervention: Overly loose sphincter repair
Number of subjects: 0
Study 35811663 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast rehabilitation program
Number of subjects: 65
Study 35811663 — intervention group
Group type: COMPARATOR
Intervention: Traditional rehabilitation program
Number of subjects: 65
Study 33981386 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous acetaminophen plus 0.1 mg/kg ondansetron intravenously
Number of subjects: 53
Study 33981386 — intervention group
Group type: COMPARATOR
Intervention: Intravenous acetaminophen plus 2 ml of normal saline intravenously
Number of subjects: 53
Study 32315287 — intervention group
Group type: EXPERIMENTAL
Intervention: Ad26.ZEBOV, MVA-BN-Filo vaccination regimen
Number of subjects: 0
Study 32315287 — intervention group
Group type: EXPERIMENTAL
Intervention: Ebola glycoprotein stimulation
Number of subjects: 0
Study 35559648 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile health intervention with smartwatch and usual care
Number of subjects: 220
Study 33221515 — intervention group
Group type: EXPERIMENTAL
Intervention: Aqueous chlorhexidine (AqCHX) 0.1%
Number of subjects: 50
Study 33221515 — intervention group
Group type: COMPARATOR
Intervention: Povidone-Iodine (PI) 5%
Number of subjects: 50
Study 33221515 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 50
Study 32671667 — intervention group
Group type: EXPERIMENTAL
Intervention: Renal replacement therapy (RRT)
Number of subjects: 151
Study 32671667 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline GFR > 60 mL/min/1.73 m2
Number of subjects: 151
Study 32671667 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline GFR < 60 mL/min/1.73 m2
Number of subjects: 151
Study 35108739 — intervention group
Group type: EXPERIMENTAL
Intervention: UpToDate
Number of subjects: 26
Study 35108739 — intervention group
Group type: COMPARATOR
Intervention: DynaMed Plus
Number of subjects: 26
Study 35108739 — intervention group
Group type: EXPERIMENTAL
Intervention: Both resources
Number of subjects: 26
Study 33158765 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab with chemotherapy (≤ 4 cycles of platinum-based chemotherapy with pemetrexed + nivolumab for ≤ 12 cycles as maintenance)
Number of subjects: 92
Study 33158765 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab with chemotherapy
Number of subjects: 92
Study 33158765 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy (≤ 4 cycles of platinum-based chemotherapy with pemetrexed)
Number of subjects: 92
Study 33479838 — intervention group
Group type: EXPERIMENTAL
Intervention: Double cow-hitch technique
Number of subjects: 12
Study 33479838 — intervention group
Group type: COMPARATOR
Intervention: Double tight-rope technique
Number of subjects: 12
Study 34068730 — intervention group
Group type: EXPERIMENTAL
Intervention: Cooling recovery (cooling suit worn on lower legs)
Number of subjects: 12
Study 34068730 — intervention group
Group type: COMPARATOR
Intervention: Control (no cooling suit)
Number of subjects: 12
Study 32940628 — intervention group
Group type: EXPERIMENTAL
Intervention: nab-paclitaxel, 260 mg/m2 every 3 weeks
Number of subjects: 199
Study 32940628 — intervention group
Group type: COMPARATOR
Intervention: paclitaxel, 175 mg/m2 every 3 weeks
Number of subjects: 199
Study 34903431 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic radiotherapy with concurrent chemoradiotherapy followed by adjuvant chemotherapy
Number of subjects: 146
Study 34903431 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality assurance in radiotherapy (QART) assessment
Number of subjects: 146
Study 34903431 — intervention group
Group type: EXPERIMENTAL
Intervention: Dosimetric evaluation using the TROG protocol
Number of subjects: 146
Study 36266668 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous feeding
Number of subjects: 90
Study 36266668 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclic feeding
Number of subjects: 90
Study 36266668 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent feeding
Number of subjects: 90
Study 35079588 — intervention group
Group type: EXPERIMENTAL
Intervention: Education via the Line application and telephone-based counseling (experimental group)
Number of subjects: 60
Study 35079588 — intervention group
Group type: COMPARATOR
Intervention: Standard routine health education activities (control group)
Number of subjects: 60
Study 36114871 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumbar facet joint osteoarthritis (LFJOA) subgroup
Number of subjects: 18
Study 36114871 — intervention group
Group type: EXPERIMENTAL
Intervention: LFJOA subgroup
Number of subjects: 18
Study 36114871 — intervention group
Group type: COMPARATOR
Intervention: Non-LFJOA subgroup
Number of subjects: 18
Study 34465828 — intervention group
Group type: EXPERIMENTAL
Intervention: ICH with advanced WMH
Number of subjects: 1454
Study 34465828 — intervention group
Group type: COMPARATOR
Intervention: ICH with mild WMH
Number of subjects: 1454
Study 34465828 — intervention group
Group type: EXPERIMENTAL
Intervention: Advanced WMH
Number of subjects: 1454
Study 34465828 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 1454
Study 36243785 — intervention group
Group type: EXPERIMENTAL
Intervention: 150-min of moderate-intensity exercise
Number of subjects: 192
Study 36243785 — intervention group
Group type: COMPARATOR
Intervention: Non-exercising control
Number of subjects: 192
Study 32944748 — intervention group
Group type: EXPERIMENTAL
Intervention: PFOA (perfluorooctanoic acid) serum concentration
Number of subjects: 648
Study 32944748 — intervention group
Group type: EXPERIMENTAL
Intervention: PFOA (highest quartile vs lowest quartile)
Number of subjects: 648
Study 32944748 — intervention group
Group type: EXPERIMENTAL
Intervention: PFOA (after adjustment for other PFAS)
Number of subjects: 648
Study 32944748 — intervention group
Group type: EXPERIMENTAL
Intervention: PFOA (restricted to individuals without diminished kidney function)
Number of subjects: 648
Study 32944748 — intervention group
Group type: EXPERIMENTAL
Intervention: PFOA (cases diagnosed 8 or more years after phlebotomy)
Number of subjects: 648
Study 34310796 — intervention group
Group type: EXPERIMENTAL
Intervention: Care Transitions Intervention (CTI)
Number of subjects: 1756
Study 34967362 — intervention group
Group type: EXPERIMENTAL
Intervention: Thick-layer technique (Exeter V40 Cemented Femoral Stem)
Number of subjects: 0
Study 34967362 — intervention group
Group type: COMPARATOR
Intervention: French paradox technique (Müller Straight Stem)
Number of subjects: 0
Study 35276486 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin 36 mg (Mel 36 group; n=6)
Number of subjects: 18
Study 35276486 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin 18 mg (Mel 18 group; n=6)
Number of subjects: 18
Study 35276486 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=6)
Number of subjects: 18
Study 33246338 — intervention group
Group type: EXPERIMENTAL
Intervention: 25-hydroxyvitamin D deficiency
Number of subjects: 1394
Study 33246338 — intervention group
Group type: EXPERIMENTAL
Intervention: Homocysteine levels
Number of subjects: 1394
Study 33246338 — intervention group
Group type: EXPERIMENTAL
Intervention: C-reactive protein (3-10 mg/L)
Number of subjects: 1394
Study 33246338 — intervention group
Group type: EXPERIMENTAL
Intervention: Gray matter volume
Number of subjects: 1394
Study 33246338 — intervention group
Group type: EXPERIMENTAL
Intervention: Hippocampal volume
Number of subjects: 1394
Study 33246338 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 index
Number of subjects: 1394
Study 34100498 — intervention group
Group type: EXPERIMENTAL
Intervention: Intact salmon
Number of subjects: 13
Study 34100498 — intervention group
Group type: EXPERIMENTAL
Intervention: Minced salmon
Number of subjects: 13
Study 34100498 — intervention group
Group type: EXPERIMENTAL
Intervention: Defatted salmon + oil
Number of subjects: 13
Study 34100498 — intervention group
Group type: COMPARATOR
Intervention: Homogeneous unstructured meal
Number of subjects: 13
Study 32856410 — intervention group
Group type: EXPERIMENTAL
Intervention: Vein viewing device
Number of subjects: 0
Study 32856410 — intervention group
Group type: COMPARATOR
Intervention: Control group (no vein viewing device)
Number of subjects: 0
Study 35748397 — intervention group
Group type: EXPERIMENTAL
Intervention: Lasmiditan 50 mg
Number of subjects: 691
Study 35748397 — intervention group
Group type: EXPERIMENTAL
Intervention: Lasmiditan 100 mg
Number of subjects: 691
Study 35748397 — intervention group
Group type: EXPERIMENTAL
Intervention: Lasmiditan 200 mg
Number of subjects: 691
Study 35748397 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 691
Study 33295007 — intervention group
Group type: EXPERIMENTAL
Intervention: Apalutamide + androgen deprivation therapy
Number of subjects: 51
Study 33295007 — intervention group
Group type: COMPARATOR
Intervention: Placebo + androgen deprivation therapy
Number of subjects: 51
Study 35278643 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc supplementation (ZnG) for 8 weeks
Number of subjects: 51
Study 35278643 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PbG)
Number of subjects: 51
Study 33692177 — intervention group
Group type: EXPERIMENTAL
Intervention: Trial protocol changes and training by the FEVER team
Number of subjects: 81
Study 33692177 — intervention group
Group type: EXPERIMENTAL
Intervention: Trial acceptability as perceived by parents and staff
Number of subjects: 81
Study 33692177 — intervention group
Group type: EXPERIMENTAL
Intervention: Concerns regarding temperature thresholds and pain management
Number of subjects: 81
Study 32825070 — intervention group
Group type: EXPERIMENTAL
Intervention: Financial rewards
Number of subjects: 0
Study 32825070 — intervention group
Group type: EXPERIMENTAL
Intervention: Smart gamification
Number of subjects: 0
Study 32825070 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of smart gamification and financial rewards
Number of subjects: 0
Study 32825070 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific motivation)
Number of subjects: 0
Study 35484828 — intervention group
Group type: EXPERIMENTAL
Intervention: Precision intraoperative nerve block with 0.3% ropivacaine
Number of subjects: 120
Study 35484828 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional analgesia (superficial cervical plexus nerve block)
Number of subjects: 120
Study 35484828 — intervention group
Group type: COMPARATOR
Intervention: Control (saline injection)
Number of subjects: 120
Study 33939289 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic soft silicone multi-layered foam dressings with loading
Number of subjects: 8
Study 33939289 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic soft silicone multi-layered foam dressings without loading
Number of subjects: 8
Study 33939289 — intervention group
Group type: COMPARATOR
Intervention: No dressings with loading
Number of subjects: 8
Study 33939289 — intervention group
Group type: COMPARATOR
Intervention: No dressings without loading
Number of subjects: 8
Study 33061332 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensified postoperative physical therapy treatment including daily supervised early mobilization and coached deep breathing exercises with positive expiratory pressure (PEP)
Number of subjects: 69
Study 34997449 — intervention group
Group type: EXPERIMENTAL
Intervention: FTD/TPI 35 mg/m2
Number of subjects: 507
Study 34997449 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 507
Study 33762689 — intervention group
Group type: EXPERIMENTAL
Intervention: Bifidobacterium longum subsp. infantis (B. infantis) EVC001 (EVC) daily for 21 days
Number of subjects: 48
Study 33762689 — intervention group
Group type: COMPARATOR
Intervention: Breast milk alone (unsupplemented (UNS))
Number of subjects: 48
Study 35321558 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-RAS inhibitors (calcium channel blockers and diuretics)
Number of subjects: 203
Study 35321558 — intervention group
Group type: EXPERIMENTAL
Intervention: RAS inhibitors (ACE inhibitors, ARBs, and β-blockers)
Number of subjects: 203